On the other hand FIT, even at the cut-off level of 200 ng Hb/ml, is more than twice as sensitive for large adenomas than gFOBT,[24] and is associated with prevention of more CRC and associated treatments. This evidence concerns the gene GSTM1 and colorectal carcinoma.